Migraine: Developing Drugs for Acute Treatment
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
February 16, 2018
April 24, 2020
39ba4b4b-6c93-4849-a087-866c6bf4edff
Related Documents
Allergic Rhinitis: Developing Drug Products for Treatment Guidance for Industry
Guidance DocumentSeptember 6, 2018Center for Drug Evaluation and Research
Hypertension: Developing Fixed-Dose Combination Drugs for Treatment
Guidance DocumentNovember 7, 2018Center for Drug Evaluation and Research
Nonallergic Rhinitis: Developing Drug Products for Treatment
Guidance DocumentSeptember 6, 2018Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.